[Form 4] Walgreens Boots Alliance, Inc Insider Trading Activity
Manmohan Mahajan, EVP and Global CFO of Walgreens Boots Alliance (WBA), reported a transaction dated 08/28/2025 disposing of 414,273 shares of WBA common stock, leaving him with 0 shares beneficially owned following the transaction. The Form 4 explains the disposition resulted from the Merger under the March 6, 2025 Merger Agreement, where each share was converted at the Effective Time into $11.45 in cash plus one Divested Asset Proceed Right. RSUs held by the reporting person were cancelled in exchange for the Per Share Consideration, although any unvested RSUs remain subject to the original vesting conditions tied to continued service.
Manmohan Mahajan, EVP e Chief Financial Officer globale di Walgreens Boots Alliance (WBA), ha segnalato una transazione del 28/08/2025 con la cessione di 414.273 azioni ordinarie WBA, rimanendo con 0 azioni possedute dopo l’operazione. Nel Modulo 4 si precisa che la cessione è derivata dalla Fusione prevista dal Contratto di Fusione del 6 marzo 2025: a ogni azione, al momento dell’Effetto, è stato corrisposto $11,45 in contanti più un Divested Asset Proceed Right. Le RSU detenute dal dichiarante sono state annullate in cambio del Corrispettivo per Azione; le RSU non ancora maturate restano comunque soggette alle condizioni di vesting originarie legate alla continuazione del rapporto di servizio.
Manmohan Mahajan, EVP y Director Financiero Global de Walgreens Boots Alliance (WBA), informó una operación fechada el 28/08/2025 en la que dispuso de 414.273 acciones ordinarias de WBA, quedando con 0 acciones tras la transacción. El Formulario 4 explica que la enajenación provino de la Fusión conforme al Acuerdo de Fusión del 6 de marzo de 2025; en el Momento de Efectividad, cada acción se convirtió en $11,45 en efectivo más un Divested Asset Proceed Right. Las RSU en posesión del declarante se cancelaron a cambio de la Compensación por Acción; las RSU no adquiridas siguen sujetas a las condiciones de adquisición originales vinculadas a la continuidad del servicio.
Manmohan Mahajan, Walgreens Boots Alliance(WBA)의 EVP 겸 글로벌 최고재무책임자(CFO)는 2025년 8월 28일자로 WBA 보통주 414,273주를 처분한 거래를 신고했으며, 거래 후 보유 지분은 0주입니다. Form 4에는 해당 처분이 2025년 3월 6일 체결된 합병계약에 따른 합병 결과라고 명시되어 있으며, 효력 발생 시 각 주식은 $11.45의 현금과 1개의 Divested Asset Proceed Right로 전환되었습니다. 신고인의 RSU는 주당 대가로 대체되어 취소되었고, 단 미확정 RSU는 계속 근무 조건에 따른 원래의 가속(vesting) 조건이 계속 적용됩니다.
Manmohan Mahajan, EVP et Directeur financier mondial de Walgreens Boots Alliance (WBA), a déclaré une opération datée du 28/08/2025 portant sur la cession de 414 273 actions ordinaires WBA, ne détenant plus aucune action après la transaction. Le formulaire 4 précise que la cession résulte de la Fusion en vertu de l’Accord de Fusion du 6 mars 2025 : à la Date d’Effet, chaque action a été convertie en 11,45 $ en numéraire plus un Divested Asset Proceed Right. Les RSU détenues par le déclarant ont été annulées en échange de la contrepartie par action ; les RSU non acquises restent néanmoins soumises aux conditions de vesting originales liées à la poursuite du service.
Manmohan Mahajan, EVP und Global CFO von Walgreens Boots Alliance (WBA), meldete eine Transaktion vom 28.08.2025, bei der er 414.273 Aktien der WBA-Stammaktien veräußerte und nach der Transaktion 0 Aktien besitzt. Im Formular 4 wird erläutert, dass die Veräußerung aus der Verschmelzung gemäß dem Fusionsvertrag vom 6. März 2025 resultierte: Zum Zeitpunkt des Wirksamwerdens wurde jede Aktie in $11,45 in bar zuzüglich eines Divested Asset Proceed Right umgewandelt. Die vom Meldenden gehaltenen RSUs wurden im Austausch gegen die Vergütung pro Aktie annulliert; nicht unverfallte RSUs unterliegen weiterhin den ursprünglichen Vesting-Bedingungen, die an die fortgesetzte Dienstzeit geknüpft sind.
- Per-share cash consideration of $11.45 was provided to the reporting person as part of the merger, ensuring cash realization for each converted share
- RSUs converted into Per Share Consideration, and unvested RSUs remain subject to original vesting, preserving compensation structure continuity
- Reporting person beneficial ownership reduced to 0 shares following the reported transaction
- Cancellation of RSUs means equity stake in the public company was eliminated at the Effective Time
Insights
TL;DR: Insider ownership reduced to zero due to merger consideration, with RSUs converted and unvested units still subject to service-based vesting.
The Form 4 documents a disposition of 414,273 shares by the EVP/CFO that is solely attributable to the corporate merger transaction. From a governance perspective, the disclosure is straightforward and consistent with merger mechanics: common stock and RSUs were converted into merger consideration rather than sold on the open market. The filing clarifies treatment of unvested RSUs, which preserves customary employment-based vesting obligations. This reduces public insider alignment but reflects deal terms rather than voluntary insider selling.
TL;DR: Disposition reflects merger consideration mechanics: per-share cash of $11.45 plus a divested-asset right; RSUs converted per the Merger Agreement.
The transaction arises from the Merger Agreement dated March 6, 2025, effective at the merger closing. Each common share converted into $11.45 cash and one Divested Asset Proceed Right, and RSUs were cancelled for the same Per Share Consideration with unvested units retaining service-based vesting. This filing documents the expected conversion of equity instruments under merger terms and explains post-closing treatment of equity awards for senior management.
Manmohan Mahajan, EVP e Chief Financial Officer globale di Walgreens Boots Alliance (WBA), ha segnalato una transazione del 28/08/2025 con la cessione di 414.273 azioni ordinarie WBA, rimanendo con 0 azioni possedute dopo l’operazione. Nel Modulo 4 si precisa che la cessione è derivata dalla Fusione prevista dal Contratto di Fusione del 6 marzo 2025: a ogni azione, al momento dell’Effetto, è stato corrisposto $11,45 in contanti più un Divested Asset Proceed Right. Le RSU detenute dal dichiarante sono state annullate in cambio del Corrispettivo per Azione; le RSU non ancora maturate restano comunque soggette alle condizioni di vesting originarie legate alla continuazione del rapporto di servizio.
Manmohan Mahajan, EVP y Director Financiero Global de Walgreens Boots Alliance (WBA), informó una operación fechada el 28/08/2025 en la que dispuso de 414.273 acciones ordinarias de WBA, quedando con 0 acciones tras la transacción. El Formulario 4 explica que la enajenación provino de la Fusión conforme al Acuerdo de Fusión del 6 de marzo de 2025; en el Momento de Efectividad, cada acción se convirtió en $11,45 en efectivo más un Divested Asset Proceed Right. Las RSU en posesión del declarante se cancelaron a cambio de la Compensación por Acción; las RSU no adquiridas siguen sujetas a las condiciones de adquisición originales vinculadas a la continuidad del servicio.
Manmohan Mahajan, Walgreens Boots Alliance(WBA)의 EVP 겸 글로벌 최고재무책임자(CFO)는 2025년 8월 28일자로 WBA 보통주 414,273주를 처분한 거래를 신고했으며, 거래 후 보유 지분은 0주입니다. Form 4에는 해당 처분이 2025년 3월 6일 체결된 합병계약에 따른 합병 결과라고 명시되어 있으며, 효력 발생 시 각 주식은 $11.45의 현금과 1개의 Divested Asset Proceed Right로 전환되었습니다. 신고인의 RSU는 주당 대가로 대체되어 취소되었고, 단 미확정 RSU는 계속 근무 조건에 따른 원래의 가속(vesting) 조건이 계속 적용됩니다.
Manmohan Mahajan, EVP et Directeur financier mondial de Walgreens Boots Alliance (WBA), a déclaré une opération datée du 28/08/2025 portant sur la cession de 414 273 actions ordinaires WBA, ne détenant plus aucune action après la transaction. Le formulaire 4 précise que la cession résulte de la Fusion en vertu de l’Accord de Fusion du 6 mars 2025 : à la Date d’Effet, chaque action a été convertie en 11,45 $ en numéraire plus un Divested Asset Proceed Right. Les RSU détenues par le déclarant ont été annulées en échange de la contrepartie par action ; les RSU non acquises restent néanmoins soumises aux conditions de vesting originales liées à la poursuite du service.
Manmohan Mahajan, EVP und Global CFO von Walgreens Boots Alliance (WBA), meldete eine Transaktion vom 28.08.2025, bei der er 414.273 Aktien der WBA-Stammaktien veräußerte und nach der Transaktion 0 Aktien besitzt. Im Formular 4 wird erläutert, dass die Veräußerung aus der Verschmelzung gemäß dem Fusionsvertrag vom 6. März 2025 resultierte: Zum Zeitpunkt des Wirksamwerdens wurde jede Aktie in $11,45 in bar zuzüglich eines Divested Asset Proceed Right umgewandelt. Die vom Meldenden gehaltenen RSUs wurden im Austausch gegen die Vergütung pro Aktie annulliert; nicht unverfallte RSUs unterliegen weiterhin den ursprünglichen Vesting-Bedingungen, die an die fortgesetzte Dienstzeit geknüpft sind.